Mycology-Nanotechnology Interface: Applications in Medicine and Cosmetology.

In today's time, nanotechnology is being utilized to develop efficient products in the cosmetic and pharmaceutical industries. The application of nanotechnology in transforming bioactive material into nanoscale products substantially improves their biocompatibility and enhances their effectiveness, even when used in lower quantities. There is a significant global market potential for these nanoparticles because of which research teams around the world are interested in the advancements in nanotechnology. These recent advances have shown that fungi can synthesize metallic nanoparticles via extra- and intracellular mechanisms. Moreover, the chemical and physical properties of novel metallic nanoparticles synthesised by fungi are improved by regulating the surface chemistry, size, and surface morphology of the nanoparticles. Compared to chemical synthesis, the green synthesis of nanoparticles offers a safe and sustainable approach for developing nanoparticles. Biosynthesised nanoparticles can potentially enhance the bioactivities of different cellular fractions, such as plant extracts, fungal extracts, and metabolites. The nanoparticles synthesised by fungi offer a wide range of applications. Recently, the biosynthesis of nanoparticles using fungi has become popular, and various ways are being explored to maximize nanoparticles synthesis. This manuscript reviews the characteristics and applications of the nanoparticles synthesised using the different taxa of fungi. The key focus is given to the applications of these nanoparticles in medicine and cosmetology.

Introduction

The advancement in nanotechnology has enabled the creation and control of the nano-sized features in devices and materials to develop novel products in agricultural, cosmetic, environmental, food, medical device, personal care, and pharmaceutical industries. The emerging nanotechnology applications rely on the cost-effective synthesis and nanocomposites or nanoparticles with a size less than 100 nm.1 In naïve conditions, the bulk material tends to have consistent physical properties. However, during synthesis, the nanoparticles undergo various changes in chemical, electrical, magnetic, and optical properties due to the changes in particle size and shape. The published literature has revealed that silver and gold nanomaterials are extensively used to synthesize cosmeceutical and medical products.2 Although inert, silver nanoparticles (Ag-NPs) work effectively with antimicrobial compounds as they elicit the production of reactive oxygen species like hydrogen peroxide, which improves the antimicrobial activity.3 Owing to this ability, these nanoparticles can be used as antimicrobial agents to decrease pathogen infections during surgery and can help overcome antimicrobial resistance. Lately, it has been discovered that Ag-NPs also exhibit anti-angiogenic, anti-permeability, and anti-inflammatory potential, which has made them an effective entity for healthcare industries.4 Gold Nanoparticles (Au-NPs) also show antimicrobial and anticancer potential, and they are extensively used for treating numerous diseases. Progressive development in nanotechnology has enabled us to develop highly stable Au-NPs with suitable electrical, photothermal and optical properties for different applications in medical diagnostics and the health care industry.5 Apart from these two metals, other metals like cadmium, iron, platinum, and zinc are also used for synthesizing metallic nanoparticles via green technology.6

Biosynthetic Zinc oxide (ZnO) NPs have been reported to show antimicrobial activity and UV-blocking properties.7 Fungal-synthesized Maghemite NPs showed good properties of decolorizing textile effluents and removing different heavy metals.8 Fouda et al biosynthesized nanocomposites consisting of Cupric oxide and zinc oxide from Penicillium that could degrade methylene blue dye. Fungal-synthesized cupric oxide NPs have also been shown to have insecticidal activity against wheat-grain insects.9 These applications notarize the real potential of biosynthetic nanoparticles with multifunctional properties. Syed and Ahmad have reported the potential of Fusarium oxysporum for the extracellular synthesis of platinum nanoparticles. Their research reports the conversion of hexachloroplatinic acid into NPs, which showed suitable characteristics upon analysis using X-ray diffraction, transmission electron microscopy (TEM), and x-ray photoelectron spectroscopy (XPS).10

The conventional chemical methods of nanoparticle synthesis impose various negative impacts like the emission of toxic residues in the environment, which affects the health of both animals and humans, and improper disposal also results in other environmental issues.11 Additionally, these methods require high-end, sophisticated instrumentation and high energy costs for effective synthesis at a commercial scale. Reports show the benefit of chemically synthesised nanoparticles with antibacterial activities. One such report on curcumin silver nanoparticles showed antimicrobial activity of these NPs.12 However, the nanoparticles are of chemical origin and have some inherent disadvantages, including low biocompatibility and toxic effects of chemicals. The development of novel approaches using plants and microbes has emerged as an effective alternative for NPs synthesis. This is referred to as the green synthesis of nanoparticles. This approach has added advantages like non-toxic end-product, higher energy efficiency, and lower cost.13 The significant advantage of the green synthesis is that nanoparticle characteristics can be customized by regulating their composition, shape, morphology, and particle size, which directs their optical properties, chemical properties, catalytic properties, and anti-microbial potential, among other properties.14,15 Owing to these properties, the fungal synthesised nanoparticles find tremendous applications in the medicine and cosmetics industry. In the medicine and therapeutics industry, the fungal synthesized nanoparticles can potentially be used as antivirals, antibacterial, antifungals, anticancer drugs, drug delivery systems (DDS), and wound-healing agents, among others.16,17 For most antimicrobial activities, the size range of the nanoparticles is kept between 4–30 nm, which is confirmed through different analytical methods such as EDS (energy dispersive spectroscopy) and SAED (selected area electron diffraction).18 However, the expected size range for antivirals is much smaller, ie, between 1–10 nm.19 The field of cosmetology also finds several applications for these nanoparticles, such as preservative agents, antimicrobial agents, anti-inflammatory and antioxidants, among others.20

Since cosmetics work mainly on the skin, therefore, the size of the nanoparticles expected to work on the skin is 10–60 nm. However, there are concentration-dependent effects on the skin because of which the concentration of these nanoparticles is kept very low and close to 1ppm only.21,22 The fungal biomass provides the necessary capping agents, which are organic (usually proteinaceous) and biologically originated.23 As a result, the nanoparticles show high biocompatibility as a general feature. Biocompatibility is one of the critical features of green-synthesized nanoparticles because of ease of binding and internalization whenever required. The potential of biosynthetic NPs is also reviewed by Alavi and Rai (2021).24 This review highlights the present knowledge regarding nanoparticles synthesis via fungal species, their market potential, physio-chemical characteristics, and applications in medicine and cosmetology.

Global Market Potential of Nanoparticle Products

Nanomaterials are ultrafine materials, ranging from 1–100 nm in size. They can be synthesized through two processes, ie, biogenic or physiochemical. There are beyond 1000 products based on nanotechnology that can currently be procured from the market. Bruker Nano GmbH, Karlsruhe, Germany (), Advanced Diamond Technologies, Romeoville, IL, USA (); Altair Nanotechnologies, Reno, NV, USA (), Nanophase Technologies Corporation, Romeoville, IL, USA (), Nanosys, Milpitas, CA, USA () and are a few dominant players in the field of nanotechnology who market products entailing nanotechnology.25 Some noteworthy mentions of nanotechnology could be made in biomedical diagnostics, healthcare, textile, and food processing industries. An investigative report presented by the BBC considered the international trade for nanotechnology-based commodities and remarked that the value of these nano-tech products in 2013 was $US22.9 billion, that expanded to approximately $US26 billion in 2014. By 2019, this marketplace was anticipated to stretch to around $US64.2 billion.

The stated growth statistics show that 19.8% was the CAGR (compound annual growth rate) from 2014 to 2019.26,27 In a study conducted by Grand View Research in 2015, there would be an expected upsurge in the global capitalism curve regarding Ag-NPs by 2022 to ~ $US2.54 billion. The statistics uncover that the CAGR will exceed 25% forecast by 2022, along with the global capitalism that surpassed $US1.30 billion in 2014. Contributing beyond 30% of the Ag-NP world market, the health care industry marked the largest implementation of NP technologies in 2014.28 With the inflating demands in technology and related commodities due to the booming research and development in North America and the European region, these countries dominate the global NP technology, as stated by the Grand View Research. The standard-bearer in research innovation and the NP market is the United States. A recent increase in expenditure on R&D in biotechnological industries of Asian countries, India and China, in particular, anticipates fortifying the progress in the international Nanotechnology market in the Asian continent. The research and development expenses of Asian manufacturers are likely to increase as a consequence of trying to acquire a more capitalistic advantage in the worldwide Nanoparticle technology market in the upcoming years.29 Increased expenditure on R&D by companies will expand the augmentation of novel Nanoparticle production techniques involving harmless microbes. Additionally, further investigations would enhance the development of unprecedented Nano-tech-based products, particularly in the field of cosmeceutical and medical industries.30,31

Mechanisms of Synthesis: Extracellular and Intracellular Biosynthesis

Fungi produce nanoparticles as a defensive response against the hazardous contaminants such as heavy metals found in the environment. When they encounter toxic metal ions in their surroundings, fungi synthesize and secrete various metabolites like protein, enzymes, or cell membrane-bound molecules that reduce the metal ions into metal nanoparticles. This occurs via multiple mechanisms such as immobilization, complexation, bio-coupling, precipitation, biosorption, co-precipitation, and ion-form modification (Figure 1). After the reduction of metal ions, they are precipitated either extracellularly or intracellularly based on the synthesis mechanism (Figure 2).32 The following section describes the salient features of the extracellular and intracellular mechanisms of nanoparticle synthesis.

Figure 1

Basic mechanism flowchart of fungal-based biosynthesis of nanoparticles.

Figure 2

Schematic representation of intracellular and extracellular nanoparticle formation by fungi.

Extracellular Fungal Biosynthesis of Metal Nanoparticles (MNPs)

Cell membranes of fungi display various molecules such as polysaccharides, quinones, peptides, oxidoreductases, proteins, etc., that are involved in reducing metal ions and precipitating them into MNPs, thus playing a vital role in the extracellular production of MNPs. Extracellular reductases are considered the chief enzymes accountable for the synthesis of MNPs.33 A study established that F. oxysporum cells produce sulphite and nicotinamide adenine dinucleotide phosphate (NADPH)- dependent nitrate reductases that synthesize Au-NPs and Ag-NPs, respectively.34 Moreover, nitrate reductases, quinones (naphthoquinones and anthraquinones), flavin adenine dinucleotide (FAD)-dependent glutathione reductase, quinine derivatives, and hydrogenases have been reported to contribute to the reduction process during fungal synthesis of MNPs. In another study by Siddiqui et al, Au-NPs synthesized using Fusarium oxysporum showed anti-proliferative activity against breast cancer and Burkitt’s lymphoma, in-vitro.35 Mukherjee et al also reported the potential of Fusarium oxysporum for extracellular synthesis of Au-NPs.36 MNPs biosynthesis by fungi through reductases needs an electron shuttle to reduce the metal ions. Research showed that fungi overexpressed some metalloproteins when exposed to a high concentration of heavy metal ions. These metalloproteins were believed to assist in the reduction of metal ions. The surface proteins bound on cell membranes of fungi have also been reported to carry out the synthesis of MNPs extracellularly.37 An investigation of R. oryzae and Coriolus versicolor revealed that the surface proteins embedded in the mycelia of these fungi assist in the reduction and stabilization of Ag ions and Au ions to biosynthesize Ag-NPs and Au-NPs.38

Intracellular Fungal Biosynthesis of Metal Nanoparticles

Enzymes such as hydrogenases and cellular ATPases are primarily responsible for the intracellular production of MNPs by fungi. Research on F. oxysporum showed the biosynthesis and aggregation of Au-NPs in the vacuoles present in the cytoplasm of fungal cells. Further analysis showed that plasma membrane-ATPase, glyceraldehyde-3-phosphate dehydrogenase, and 3-glucan binding protein regulated the intracellular synthesis of Au-NPs. Metallothionein and phytochelatin (metal-binding proteins), along with glutathione, are involved in the metal detoxification in yeasts leading to the reduction of metal ions to MNPs as they possess specific nucleophilic and redox properties.39 Fungi also use their antioxidants to precipitate these metal ions into MNPs to prevent cell damage through oxidation by these toxic metal ions. Toxic metal ions can also penetrate the cytosol of fungal cells through transporter proteins and membrane channels present in the cell membrane of fungi. Upon attack by metal ions, the fungal cells obstruct or eradicate such transport systems through which metal ions can enter. However, this defensive response of fungal cells affects the ongoing cellular processes, and some metal ions still penetrate the cytoplasmic space via multiple transport systems. In such a scenario, the intracellular fungal enzymes react with these metal ions to precipitate them into MNPs.40

Green Synthesis of Metal-Based Nanoparticles

The widespread application of MNPs in the medical sector has made it necessary to develop sustainable ways to produce MNPs that circumvent the usage of hazardous chemicals. The advancements in nanotechnology have enabled the evolution of traditional methods to more sustainable and versatile methods to produce Ag-NPs with controlled and explicit properties.41 Usually, NPs are synthesized either by the “top-down method” or “bottom-up method” (Figure 3).

Figure 3

Diagrammatic illustration of top-down method” and “bottom-up method.

In the bottom-up method, there is a homogeneous system wherein the catalytic agents such as enzymes and reducing agents control the catalysis of the synthesis of NPs. At the same time, appropriate pH, exposure time and temperature, and stabilizer provide the necessary environment for efficient bioprocessing of NPs. Moreover, reaction conditions and precursor concentrations determine the physicochemical attributes of NPs like morphological properties and surface structure.42 On the other hand, the top-down method uses the material in bulk form, and the size is reduced to nanoscale by physical treatment, chemical treatment, or their combination. Size reduction by physical treatment drastically increases the energy consumption, and therefore, is generally not preferred. This drawback paves the way for the chemical treatment to be the most common synthetic pathway for synthesizing MNPs. Using these approaches, both negatively charged and positively charged Ag-NPs can be synthesized.43 Negatively charged Ag-NPs can be synthesized using sodium citrate acting as a reducing agent, while positively charged Ag-NPs can be produced from the process using ethylene diamine tetra acetic acid (EDTA), branched polyethyleneimine, citrate, formaldehyde, hydrazine, alkali metals in ammonia, acetonitrile, inorganic and organic borohydrides, polyols, ascorbic acid, mono-alcohols or free radicals. A serious biological and environmental risk is posed by the top-down method as it uses various harmful solvents, reducing agents, and additives that are even unsuitable for medical use.44 Therefore, for the large-scale production of MNPs, it becomes essential to create eco-friendly, non-toxic precipitation processes. The green synthesis of MNPs by microbes focuses on increasing cell mass and synthesizing specific metabolites which act as reducing and capping agents. The primary purpose of this emphasis is to obtain homogeneous MNPs having uniform size, shape, and desirable optical properties such as the band gap energy, UV-visible absorption, and absorption coefficient, among others. Having desirable optical properties is essential for MNPs as they have to be employed for various purposes such as chemical, biological, medical, and electronic, among others.45

Applications of Microbial-Derived Nanoparticles

Much literature is available regarding the wet synthesis of MNPs by microbes. To survive in heavy metal contaminated areas, microbes naturally produce metal-binding peptides and proteins that bioremediate heavy metals. This characteristic of microbes gives an advantage to the microbial synthesis of MNPs over traditional MNP synthesis approaches. Microbes are called efficient bio-factories of NPs as they synthesize large quantities of enzymes, vitamins, polysaccharides, amino acids, and proteins which act as capping and reducing agents to reduce metal ions. Being potential bio-factories of MNPs, microbes can produce several NPs such as silver, titanium, gold, palladium, cadmium, platinum, etc. Among microbial species, bacteria, lower fungi, yeasts, edible mushrooms, and algae have been reported to synthesize MNPs. To prevent contamination by toxic metabolites, the microbe used for biosynthesis of MNPs must belong to either GRAS (generally regarded as safe) or Risk group 1 as classified by USFDA and WHO, respectively. Owing to this, much research has been carried out on edible mushrooms and lactic acid bacteria for the production of MNPs for use in food and nutraceutical industries. The following section discusses the applications of nanoparticles derived from different bacterial taxa.

Bacteria

Bacterial-synthesized nanoparticles have several reported potential applications that have been mentioned as follows. Green synthesised silver nanoparticles from different species of Streptomyces showed considerable antimicrobial and insecticidal activities.9 Ag-NPs derived from Bacillus sp. SBT8 showed antimicrobial activity.49 Pseudomonas aeruginosa-derived ZnO NPs showed significant antimicrobial activity against pathogens such as Candida albicans, E. coli (MIC 50ppm), and Staphylococcus aureus (MIC 200ppm).50 The extracellular biosynthesis of NPs is preferred over intracellular biosynthesis as it has simple and cheap downstream processing and does not require additional steps to optimize the process and break the cells to release NPs.51 Although bacteria have been reported to yield nanoparticles with different biological properties as reviewed above, fungal nanoparticles have been consistently gaining attention because of relatively higher biomass and convenient extraction of the filtrate.52

Fungi

Fungal NPs are produced extracellularly and offer certain advantages such as the production of stable NPs, synthesis of NPs is achieved in a single step, minimal use of complex chemicals, and no contamination by toxic metabolites.53 Botrytis cinerea is known to produce extracellular Au-NPs of varying shapes such as hexagonal, pyramidal, spherical, decahedral, and triangular. Studies have reported the production of both intracellular and extracellular NPs by Aspergillus oryzae var. viridis with sizes ranging between 10 and 60 nm.54 The biggest flex is that the fungal NPs biosynthesis can be carried out in a controlled manner allowing the production of NPs with desirable characteristics like shape, stability, size, and particle dispersity. Chemical stability, conductivity, antibacterial and catalytic activity of NPs is inversely related to their size, ie, the smaller the size of NPs higher will be the aforementioned properties. Small NPs with uniform dispersion have the advantage of possessing greater surface area, but the latter may also negatively affect the surface reactivity of NPs and reduce their stability in solutions. Attempts have been made to control the size of NP during biosynthesis, which usually involves optimization of pH and metal ion concentration at the start of the process.55 Ag-NPs derived from Penicillium italicum showed antioxidant activity (radical-scavenging) against DPPH and showed a dose-dependent antimicrobial activity against Candida tropicalis, Candida albicans, Staphylococcus aureus, and E. coli.56 Fungal synthesized Ag-NPs derived from Fusarium keratoplasticum showed significant growth inhibition of S. aureus, B. subtilis, P. aeruginosa, and E. coli when applied to cotton fabric in washing cycles.57 Fungal-derived Fe2O3 and MgO NPs (derived from Aspergillus carbonarius D-1) also showed biodegradation of different textile compounds in tannery effluent. The study also revealed immense potential in removing heavy metals from the effluent. Chromium was significantly removed from the water, whereas the MgO and Fe2O3 NPs were also effective in removing cadmium, lead, and nickel.58 MgO NPs synthesized from Penicillium chrysogenum could control the propagation of the malarial vector Anopheles stephensi through insecticidal activity against both larvae instar, pupal stages, and adult stages.59

Filamentous fungi have been widely studied for the biosynthesis of MNPs. Fungal synthesis of MNPs is considered an efficient and green approach for producing MNPs. Fungi are known for their ability to produce large quantities of extracellular metabolites, which play an important role in maintaining homeostasis and increasing their chances of survival during stress conditions like the presence of toxic contaminants or lack of nutrients. This ability of fungi benefits the NP biosynthesis process as the extracellular metabolites produced by fungi act as potential reducing agents.60 Extracellular proteins and enzymes secreted by fungi reduce metal ions into stable inorganic solid MNPs, which do not require external application capping agents.

Moreover, fungal MNPs exhibit good dispersion properties. Fungi can also tolerate high metal ion concentrations during the process, making them a suitable candidate for NP synthesis. Among microorganisms, fungi are preferred over other microorganisms owing to their low energy consumption, low process cost, high productivity, easy separation of biomass from broth, and simple downstream processing.61

A study by Balakumaran et al reported the production of extremely stable and well-dispersed spherical Ag-NPs by Guignardia mangiferae with particle size ranging between 5nm to 30 nm. This study synthesized Ag-NPs at pH 7 exhibited maximum antibacterial activity. Aureobasidium pullulans and Neurospora crassa have also been reported to produce Au-NPs but are intracellular; thus, they require additional steps for purification.62 Penicillium sp. has been shown to produce both extracellular and intracellular MNPs. Chan and Mat Don (2013) were successful in obtaining a yield of about 98.9% of Ag-NPs using Pycnoporus sanguineus. The metal ions from the broth were absorbed onto the cell surface of P. sanguineus by functional groups on the cell wall. The reducing sugars from the polysaccharide hydrolysates of the biomass reduced the metal ions into MNPs. The synthesized Ag-NPs were found to be spherical, with the diameter ranging between 52.8nm to 103.3 nm.63 A wide range of fungi like Aspergillus sydowii, Penicillium brevicompactum, Botrytis cinerea, Alternaria alternata, Trichoderma reesei, Fusarium semitectum, Aspergillus clavatus, Hormoconis resinae, Aspergillus fumigatus, Aspergillus terreus, Aspergillus oryzae var. viridis, etc. have been studied for the biosynthesis of Au-NPs and Ag-NPs. The primary focus has been on Au-NPs and Ag-NPs due to their widespread application in the cosmetic and medical sectors.64

Edible and Medicinal Mushrooms

A study showed that edible and medicinal mushrooms like Pleurotus florida, Agaricus bisporus, Ganoderma applanatum, Helvella lacunosa, and Fomes fomentarius are potent bio factories of Ag-NPs. Among all these mushrooms, Agaricus bisporus was found to be the most potent mushroom for the production of Ag-NPs. It has been observed that 75% of mushroom extracts are enriched proteins essential for the synthesis of MNPs. Moreover, they are also rich in volatile organic compounds like benzaldehyde, octanols, and octanones which work as reducing agents to reduce metal ions into MNPs.65 A study established the importance of enzymes and proteins secreted by Tricholoma matsutake in reducing metal ions. The protein and enzymes oxidized benzaldehyde into a carboxylic acid, which was confirmed by FTIR analysis. A band shift of carbonyl and hydroxyl groups was seen with the diminishing of existing carbonyl groups and the appearance of a new carbonyl peak. Ag ions bonded to hydroxyl groups reflected in a broad spectrum of the IR peak obtained at 3400 cm−1 in the FTIR spectrum of Ag-NPs. The presence of proteins during the biosynthesis and stabilization of Ag-NPs was confirmed when a band spectrum was detected at 1640 and 1550 cm−1 showing the extending vibrations of the secondary and primary amines.66

Many mushrooms show the potential to produce both extracellular and intracellular MNPs. Since Pleurotus sp. has GRAS status, it has been widely employed for the synthesis of non-toxic MNPs. Al Bahrani et al investigated the role of aqueous extract of the Pleurotus ostreatus in the synthesis of spherical Ag-NPs and found that it worked as a reducing and stabilizing agent during the synthesis process. It provided an eco-friendly and efficient system for the biosynthesis of Ag-NPs. Moreover, size and morphological analysis by transmission electron microscopy (TEM) revealed the sole presence of spherical Ag-NPs with particle size ranging between 10nm to 50 nm.67 Another study established that Pleurotus florida exhibits high potential for the production of Au-NPs using chloroauric acid (HAuCl4) with a glucan that acts as both a reducing agent as well as a stabilizing agent. P. florida exhibited size-controlled biosynthesis of Au-NPs.68 Moreover, studies have also shown intracellular production of stable Au-NPs in the mycelia of Flammulina velutipes upon incubation in chloroauric solution. These Au-NPs were found to possess catalytic activity against two major organic contaminants, 4-nitrophenol and methylene blue.69 Research on Cordyceps militaris showed the potential of this mushroom to synthesize spherical shaped, highly crystalline, and stable Ag-NPs with an average width of approximately 15 nm. The synthesized Ag-NPs showed considerable antibacterial activity against various pathogenic bacterial strains.70 A study on Ganoderma sp. reported the production of uniformly sized, highly stable Ag-NPs with a diameter of about 2 nm as observed under a Transmission Electron Microscope (TEM). Moreover, it was found that extracts of Ganoderma sp. contain reducing and capping agents that are responsible for the synthesis of these Ag-NPs.71 The list of different fungal species used to synthesize different nanoparticles have been comprehended in Table 1.

Table 1

List of Fungal Species Used for Biosynthesis of Nanoparticles

Species Name	Localization		Substrate(s)	Reaction Conditions	Average Size of NPs	Biological Properties	Nanoparticles		References
	Extracellular	Intracellular					Au-NPs	Ag-NPs
Agaricus bisporus	✓		Silver Nitrate	Not Reported	103.57nm	Cytotoxic		✓	[72]
Alternaria alternata	✓		Chloroauric Acid	Fungal culture filtrate	12±5nm	Not Reported	✓		[73]
Aspergillus clavatus	✓		Silver Nitrate	Fungal culture filtrate	Not Reported	Antimicrobial against MRSA and MRSE	✓	✓	[74,75]
Aspergillus flavus	✓		Chloroauric Acid; Silver Nitrate; Tetra-chloroauric acid	Culture Supernatant; Fungal culture filtrate; Culture supernatant and filtrate	12 nm; Not reported; 17.76 nm, 22.6, and 26 nm	Cytotoxic and Catalytic; Antimicrobial against Multidrug-Resistant Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa	✓	✓	[76–78]
Aspergillus fumigatus	✓		Silver Nitrate	Cell-Free Filtrate	0.681 nm	Antibacterial activity against MDR bacterial strains like Acinetobacter, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa		✓	[79]
Aspergillus ochraceus	✓		Silver Nitrate	Fungal culture filtrate	5.5–24.4 nm	Antibacterial activity against MRSA when used in combination and Cytotoxic activity against HCT, HepG2, MCF-7, and Vero cell line		✓	[80]
Aspergillus oryzae var. viridis	✓		Chloroauric acid; Silver Nitrate	Fungal culture filtrate and Cell-free Extract; Fungal culture filtrate	10–60 nm; 5–50 nm	Not Reported; Antibacterial against Staphylococcus aureus	✓	✓	[81,82]
Aspergillus sydowii	✓		Chloroauric Acid	Fungal Culture Filtrate	8.7–15.6 nm	Not Reported	✓		[83]
Aspergillus terreus	✓		Silver Nitrate; Chloroauric acid; Silver Nitrate	Fungal Culture Filtrate; Extracellular Filtrate; Fungal Culture Filtrate	10–18 nm; 10–19 nm; 16.54 nm	Antifungal Activity against Aspergillus niger, Aspergillus ochraceus, and Aspergillus parasiticus; Antibacterial activity against Escherichia coli; Antibacterial activity against Escherichia coli, Salmonella typhi, and Staphylococcus aureus	✓	✓	[84–86]
Aureobasidium pullulans		✓	Chloroauric Acid; Silver Nitrate	Fungal Culture Filtrate; Extracellular Filtrate	11 ± 5 nm; 2.43–53.5 nm	Anticancer Drug Delivery System; Antibacterial activity against MDR pathogens like Escherichia coli, Moraxella sp., Pseudomonas sp., Salmonella typhi, and Staphylococcus aureus	✓	✓	[87,88]
Botrytis cinerea	✓		Chloroauric Acid	Cell-Free Filtrate	1–100 nm	Not Reported	✓		[89]
Chrysosporium tropicum	✓		Chloroauric acid and Silver Nitrate	Fungal Culture Filtrate	2–15 nm and 20–50 nm	Anti-parasitic activity	✓	✓	[90]
Cladosporium cladosporioides	✓		Silver Nitrate; Chloroauric acid	Fungal Culture Filtrate	100 nm	Antioxidant Activity and Antimicrobial activity against Bacillus subtilis, Candida albicans, Escherichia coli, Staphylococcus aureus, and Staphylococcus epidermis; Antioxidant and Antimicrobial activity against Aspergillus niger, Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus	✓	✓	[91,92]
Cochliobolus lunatus		✓	Silver Nitrate	Fungal Culture Filtrate	3–21 nm	Anti-parasitic activity		✓	[93]
Coriolus versicolor	✓	✓	Silver Nitrate	Fungal Crude Extracts	100 nm	Anticancer activity against HT-29, HUH-7, and MCF-7, wound healing examined on L929 cells, Antibacterial activity against Enterococcus faecalis, Klebsiella pneumonia, Pseudomonas aeruginosa, Staphylococcus aureus and antifungal activity against Candida albicans and Candida utilis		✓	[94]
Cryphonectria sp.		✓	Silver Nitrate	Fungal Culture Filtrate	30–70 nm	Antibacterial activity against Candida albicans, Escherichia coli, Salmonella typhi, and Staphylococcus aureus		✓	[95]
Flammulinavelutipe	✓		Silver Nitrate	Fungal Culture Extract	22 nm	Antibacterial activity against Aeromonas punctata, Vibrio harveyi, Vibrioalginolyticus, Vibrio anguillarum,Vibrio parahaemolyticus,and Vibrio splendidus		✓	[96]
Fusarium oxysporum	✓	✓	Silver Nitrate; Chloroauric acid	Fungal Culture Filtrate; Culture Supernatant	10–20 nm; 25–50 nm; 20–30 nm	Not Reported; Antibacterial activity against Bacillus cereus, Escherichia coli, MDR Bacillus cereus, MDR Escherichia coli, MDR Pseudomonas aeruginosa, MRSA, Pseudomonas aeruginosa, and Staphylococcus aureus	✓	✓	[97–99]
Fusarium semitectum	✓		Chloroauric acid and Silver Nitrate	Fungal Culture Filtrate	18–80 nm	Not Reported	✓	✓	[100]
Fusarium solani	✓		Chloroauric acid; Silver Nitrate	Fungal Culture Filtrate	40–45 nm; 10 nm; 20–50 nm	Cytotoxic activity against HeLa and MCF-7 Cell line	✓	✓	[101–103]
Hormoconis resinae	✓	✓	Chloroauric acid; Silver Nitrate	Fungal Culture Filtrate; Fungal Biomass	3–20 nm; 20–80 nm	Not Reported	✓	✓	[104,105]
Mucor hiemalis	✓		Silver Nitrate	Fungal Culture Filtrate	5–15 nm	Antibacterial activity against Aeromonas hydrophila, Bacillus cereus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas brassicacearum, and Staphylococcus aureus and Antifungal Activity against Aspergillus flavus, Candida albicans, and Fusarium oxysporum		✓	[106]
Neurospora crassa		✓	Chloroauric acid and Silver Nitrate; Chloroauric acid	Fungal Culture Filtrate; Fungal Extract	11 and 32 nm; 10–200 nm	Not Reported	✓	✓	[107,108]
Neurospora intermedia	✓	✓	Silver Nitrate	Fungal Culture Supernatant and Cell-Free Filtrate	19–84 nm	Antibacterial Activity against Escherichia coli		✓	[109]
Penicillium fellutanum	✓		Silver Nitrate	Fungal Culture Filtrate	5–25 nm	Not Reported		✓	[110]
Penicillium brevicompactum	✓		Chloroauric acid; Silver Nitrate	Fungal Cell Filtrates and Live Biomass; Fungal Cell-Free Extract; Fungal Culture Filtrate	20–80 nm; 6.28–15.12 ± 0.8 nm; 40–50 nm	Cytotoxic Activity against mouse mayo blast cancer C2C12 cells; Antibacterial Activity against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus; Antibacterial Activity against Escherichia coli, Proteus vulgaris Staphylococcus aureus, Staphylococcus epidermidis, and Vibrio cholerae, and Cytotoxic activity against MCF-7	✓	✓	[111–113]
Penicillium chrysogenum	✓		Chloroauric acid	Fungal Culture Filtrate	2–20 nm	Not Reported	✓		[114]
Phanerochaete chrysosporium	✓		Silver Nitrate	Fungal Cytoplasmic Fluid	26–63 nm	Not Reported		✓	[115]
Phoma glomerata	✓		Silver Nitrate	Fungal Cell Filtrate	60–80 nm	Antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus		✓	[116]
Phoma sorghina	✓		Silver Nitrate	Fungal Culture Filtrate	120–160 nm	Not Reported		✓	[117]
Pleurotus sapidus	✓		Chloroauric acid	Fungal Culture Filtrate	15–100 nm	Not Reported	✓		[118]
Pleurotus sajor caju	✓		Silver Nitrate and Chloroauric acid	Fungal Culture Filtrate	23 nm and 37 nm	Anti-proliferative activity, Anti-oxidant activity, and Cytotoxic activity against HCT-116	✓	✓	[119]
Rhizopus oryzae	✓		Chloroauric Acid	Fungal Biomass	28–52 nm	Not Reported	✓		[120]
Rhizopus stolonifer	✓		Silver Nitrate	Fungal Cell Extract	9.47 nm	Not Reported	✓		[121]
Rhodotorulaglutinis	✓		Silver Nitrate	Fungal Culture Filtrate	15.45 ± 7.94 nm	Antifungal Activity against Candida parapsilosis, Catalytic Activity, and Cytotoxic activity against HK-2		✓	[122]
Saccharomycescerevisiae	✓	✓	Silver Nitrate	Fungal Extract; Fungal Cell-Free Extract	10 nm; 16.07 nm	Photocatalytic Activity; Antibacterial Activity against Pseudomonas aeruginosa and MRSA	✓	✓	[123,124]
Schizophyllumcommune	✓	✓	Silver Nitrate	Fungal Culture Filtrate and Culture Supernatant	32.08 nm	Antimicrobial activity against Aspergillus niger, Candida albicans, Escherichia coli, Staphylococcus aureus, and Staphylococcus epidermidis		✓	[125]
Trichoderma harzianum	✓		Silver Nitrate; Chloroauric acid; Silver Nitrate	Fungal Culture Filtrate; Fungal Biomass; Fungal Free Cell Filtrate	40–60 nm; 26–34 nm; 51.10 nm	Antifungal Activity against Fusarium oxysporum, Fusarium roseum, Fusarium semitectum, and Fusarium solani; Catalytic activity and Antibacterial Activity against Escherichia coli; Antibacterial Activity against Klebsiella pneumonia and Staphylococcus aureus	✓	✓	[126–128]
Trichoderma reesei	✓		Silver Nitrate	Fungal Cell-Free Water Extract	1–25 nm	Not Reported		✓	[129]
Trichoderma viride	✓		Silver Nitrate	Fungal Cell Filtrate	1–50 nm	Antibacterial Activity against Acinetobacter baumannii, MRSA, Salmonella typhimurium, Shigella boydii, and Shigella sonnei		✓	[130]
Trichoderma asperellum	✓		Silver Nitrate	Fungal Cell-Free Water Filtrate	13–18 nm	Not Reported		✓	[131]

Abbreviations: nm, nanometer; MRSA, Methicillin-resistant Staphylococcus aureus; MRSE, Methicillin-Resistant Staphylococcus epidermidis; MDR, Multidrug-Resistant; Au-NPs, Gold Nanoparticles; Ag-NPs, Silver Nanoparticles.

Benefits of Fungal Biosynthesis Over Other Biosynthesis Methods

It is well-established now that biological production processes are more efficacious than chemical-based processes regarding the costs, capacities, and procedures for metal NPs.33 Furthermore, there is the requirement for toxic solvents and additional treatment steps in chemical processes.132 There is high potential in biologically synthesized NPs by virtue of their chemical, optical and electronic features.133

The competent nature of fungi enables them to be used for the biosynthesis of NPs over other bacteria and plants. Cellular organization and metabolic activities are more developed in fungi than bacteria.134 Fungi have higher growth rates, fewer cultivation requirements, and high maximal yields with regards to the initial raw material in comparison to bacteria.107 The recovery of NPs produced by bacteria is complex compared to fungi that produce extracellular NPs that are much easier and cheaper to recover.135 Furthermore, the unwanted debris generated from production media and fungal biomass during the production of NPs from fungi can function as organic fertilizers and is easily biodegraded.136 The selection of fungi employed for the development of metal NPs on a large-scale is based upon some characteristics, including easy downstream process, rapid growth rate, easy biomass handling, and synthesis of surplus amount of enzymes and extracellular proteins.132,137–139 Contrarily, many mushrooms studied are either plant or human pathogens, besides studies being focused on the use of safe edible mushrooms. This fact makes them inappropriate to be used in productions on an industrial scale.136 A comparative schematic of bacterial and fungal biosynthesis of nanoparticles is shown in Figure 4

Figure 4

Comparative schematic showing the bacterial and fungal mediated nanoparticle synthesis.

Compared to plants, the fungal extracts perform better for metal nanoparticle synthesis. One of the critical reasons for this observation is the complex metabolome of plants. Because of high complexity, the plant extracts are highly heterogenous and variable in their biochemical composition. Therefore, the cost of standardization of the process increases. On the other hand, the maintenance cost of aseptic conditions for fungal cultures is saved in plant-mediated nanoparticle synthesis. In our opinion, the cost-benefit does not outweigh the efficacy of the fungal synthesis of nanoparticles. Due to the heterogeneity of plant extracts, the scale-up of the process is likely more tedious and, therefore, is a significant setback.

Applications of Fungal Nanoparticles in the Medical Field

The list of fungal nanoparticles having medical applications has been summarized in Table 2.

Table 2

Enlist of Fungal Nanoparticles Showing Medical Applications

Species	Shape	Size (nm)	Nanoparticles					Application					References
			Ag	Au	Pt	TiO2	ZnO	AB	AF	AV	AC/CT	DD
Amylomyces rouxii KSU-09	•	5–27	✓					✓	✓				[140]
Aspergillus clavitus	–	550–650	✓					✓	✓				[74]
Aspergillus flavus	•	62–74				✓		✓	✓				[141]
Aspergillus fumigatus	•	15–45	✓							✓			[142]
Aspergillus niger	•	3–30	✓					✓	✓				[143]
Aspergillus niger	•	14–645	✓						✓				[144]
Aspergillus niger	•	53–69					✓	✓					[145]
Candida albicans	–	20–80		✓							✓		[146]
Cladosporium perangustum	•	30–40	✓								✓		[147]
Cladosporium sp.	•	5–10		✓							✓		[148]
Fusarium oxysporum	•	20–50	✓					✓					[149]
Macrophomina phaseolina	•	5–40	✓						✓				[150]
Morchella esculenta	•	16.5		✓				✓	✓		✓		[151]
Penicillium brevicompactum	•	10–50		✓								✓	[152]
Penicillium chrysogenum	•	5–40			✓						✓		[153]
Penicillium oxalicum	•	60–80	✓					✓					[154]
Penicillium sp.	•	25–30	✓					✓					[155]
Phoma glomerata	•	60–80	✓					✓					[116]
Pleurotus sajor caju	•	30.5	✓					✓					[151]
Trichoderma harzianum	•	32–44		✓				✓					[126]
Trichoderma longibrachiatum	•	10	✓						✓				[156]
Trichoderma viride	• and /	5–40	✓					✓					[157]
Verticillium sp.	•	25	✓					✓	✓				[158]

Abbreviations: •, Spherical; /, Rod; Au, Gold; Ag, Silver; Pt, Platinum; TiO2, Titanium Dioxide; ZnO, Zinc Oxide; AB, Anti-bacterial Activity; AF, Anti-fungal Activity; AV, Anti-viral Activity; AC/CT, Anti-cancerous Activity/Cancer Therapy; DD, Drug Delivery.

Antibacterial Activity

Heavy use of antibiotics due to epidemics in the last few years, improper diagnosis, or self-medication has resulted in an increased resistance towards the microbes and their usual treatment drugs, i.e., antibiotics. NPs can be deemed as an effective measure to combat the resistance and devise new treatment methods.159,160 Studies depict that the biosynthesized Ag-NPs from Aspergillus niger exhibit inhibitory action against E. coli, a gram-negative bacteria, and S. aureus, a gram-positive bacterium. Ag-NPs bio-formulated by Sudhakar et al through Agaricus bisporus, an edible mushroom used as a bio-reductant, had antimicrobial action against harmful bacteria including Klebsiella spp., E. coli, and Proteus vulgaris.161 With reference to the study conducted by Durán and his associates (2007), the extracellular Ag-NPs produced by Fusarium sp. had the potential to be used to treat the textile fabrics as the cells of S. aureus were destroyed upon the exposure of fabric with Ag-NPs.162 It was concluded by Fayaz et al, based on their studies, that the growth of E. coli could be curbed with a MIC (Minimum Inhibitory Concentration) of 30 μg/mL by exposing the cells to biologically synthesized Ag-NPs produced through Trichoderma viride.163 Verma et al 2009 suggested that Aspergillus clavatus can be recognized as a biological factory to synthesize Ag-NPs. These NPs have an antimicrobial action against various human pathogens, including E. coli, P. fluorescens and C. albicans.75 Another researcher conducted a study in which he firstly screened around 20 strains of fungi and the results stated that two strains each of Trichoderma sp., Aspergillus sp., and Rhizopus sp. could be used for the biological synthesis of Ag-NPs that exhibited an antimicrobial action against bacteria including P. aeruginosa, E. coli and S. aureus.164 Govindappa et al, in their study, confirmed through SEM analysis the antibacterial action of Ag-NPs synthesized using the fungus Penicillium against P. aeruginosa and E. coli and also depicted that at higher concentrations, these Ag-NPs also exhibited anti-inflammatory, antioxidant, tyrokinase and anti-lipoxygenase nature.165 The microscopic analyses of atomic force and transmission electron microscopes revealed that the particle size of the biosynthesized Ag-NPs varied between the range of 4-30 nm. The composition and crystalline nature of Ag-NPs was established through EDS (energy dispersive spectroscopy), SAED (selective area electron diffraction), and XRD (X-ray diffraction) analyses. A schematic diagram of the mechanism of antibacterial activity of functionalized metallic nanoparticles is shown in Figure 5.166

Figure 5

Schematic diagram showing the mechanism of antibacterial activity of functionalized metallic nanoparticles [Image Courtesy: 166. Under CC-BY license].

Antifungal Activity

Scientists worldwide have been trying to develop novel formulations to be used as effective treatments against the fatal diseases caused due to pathogenic microbes. Ag-NPs serve as potential candidates for the treatment of several diseases.167 Ag-NPs have been concluded to be used in formulations of products to be used in the treatment of nosocomial infections.167–171 An instance of biosynthesized Ag-NPs can potentially be used to treat nosocomial infections caused by the fungus Candida sp. The Ag-NPs possess antifungal action, synthesized through Bionectria ochroleuca and Aspergillus tubingensis. At 0.11–1.75μg/mL concentration, these Ag-NPs can destroy the fungus.172 A study by Ishida et al stated an approach of green chemistry (integrated microbial and nanotechnology) to synthesize NPs from the fungus Fusarium oxysporum. The NPs thus produced suppressed the outgrowth of pathogens, including Cryptococcus neoformans and Candida spp., as they exhibited a potentially high antifungal action. The fungal cells are killed due to the destruction of cells walls and damage to cytoplasmic membranes.173

Furthermore, the production of Ag-NPs by Schizophyllum commune, resulted in NPs with antifungal action against human fungal pathogens, essentially, dermatophytes, including Trichophyton rubrum, Trichophyton simii, and Trichophyton mentagrophytes.174 In a study conducted by Xue et al, the antifungal action of Ag-NPs biosynthesized from Arthroderma fulvum was studied.175 The study results depicted that Ag-NPs could destroy around ten human fungal pathogens when used at concentrations from 0.125 to 4.00 μg/mL, including Aspergillus spp., Fusarium spp., and Candida spp.

Antiviral Activity

Besides having antibacterial and antifungal properties, NPs also have antiviral properties. Antiviral action against HIV-1 has been recorded by Ag-NPs bio-manufactured from the fungus Aspergillus fumigatus. Research conducted by Narasimha et al stated that at a concentration of 30–180 ppm, the Ag-NPs produced by Aspergillus sp. exhibit antiviral action and decrease the no. of plaques and at a higher concentration ranging from 210–240 ppm, there is a complete suppression of virus particles in the bacterial cell host resulting in a total halt in the replication of virus.176 Studies conducted by Narasimha et al and Elechiguerra et al have concluded that the Ag-NPs ranging in size from 1–10 nm could prevent the HIV-1 virus from attaching to the host cell surface by binding to it.176,177

Anticancer Therapy

One of the major causes of fatalities worldwide is cancer. Scientists and researchers strive to establish less toxic and more effective treatments against cancer since chemotherapy has only been partially successful. Patients often acquire resistance to the chemicals or agents used in chemotherapy.178,179 According to various studies, free radicals are generated due to the induction of apoptotic pathways as a result of the administration of biogenic Ag-NPs.180 Hence, the use of Ag-NPs can serve as a diagnostic tool and for treatment of cancer in humans.180,181 Ag-NPs are reviewed to be successful angiogenic agents as they have anti-proliferative agents and anti-tumour properties. Cryptococcus laurentii (BNM0525), a yeast that biologically produces Ag-NPs has shown a potential anti-tumour behaviour in the cell lines of breast cancer, namely, T47D and MCF7.180 The cytotoxic effects caused by Ag-NPs breast cancer cells were examined by Gurunathan and his associates in 2013.182 They synthesized Ag-NPs biologically from Ganoderma neo-japonicum mycelia and concluded that the growth and activity of the breast cancer cells were restrained, accompanied by leakage in the cellular membrane after exposing the cells to solutions of Ag-NPs for 24 hrs at concentrations of 1 to 10 μg/mL. The anticancerous potential of Ag-NPs, formulated in broth cultures (shaken), with concentrations of 10-100 μg/mL, was also probed by Arun et al,174 who stated the results in terms of an MTT cytotoxicity assay that depicted around 27.2% - 64% cell death in human laryngeal carcinoma cells (HEP-2). Apart from the Ag-NPs, the Au-NPs are also reported to have anticancer properties. Basu et al reported that the green-synthesized Au-NPs using Tricholoma crassum showed dose-dependent induction of DNA damage and apoptosis in eukaryotic cells as revealed through comet assays.183 In an interesting development, Vahidi et al reported the synthesis of fungal-based tellurium nanoparticles. These NPs showed cytotoxicity against breast cancer cell line MCF-7 (IC50 39.83 μg/mL). Additionally, these tellurium nanoparticles showed significant antioxidant potential.184 Bhat and coworkers reported a unique photobiosynthetic mechanism of Au-NPs from Pleurotus florida. These functionalized Au-NPs showed in-vitro anticancer property against lung cancer cell line A549, chronic myelogenous leukaemia cell line K-562, cervix cancer cell line HeLa and mammary gland adenocarcinoma cell line MDA-MB.185

Drug Delivery

Drug delivery has been prospected to be a promising application for Nanoparticles where they can be used as carriers.186 Several mortal illnesses, including diabetes, cancer, and microbial infections, have been treated using novel drug delivery systems rooted in nanotechnology. This has also been applied to gene therapy.187 The application of this kind of drug delivery is advantageous due to its target specificity since it majorly affects the infected cells, thereby reducing the drug toxicity towards normal or uninfected cells. This improves the safety profile of the drug.188 Various approaches like quantum dots, nanotubes, nanopores, dendrimers, and liposomes release the bioactive compounds at the target-specific site(s) by coupling the drugs to NPs.187 For instance, regarding immunocompatibility and toxicity, Au-NPs are considerably safe and hence are used to formulate the scaffolds of drug delivery. A substitutive treatment for diabetes mellitus is the biologically synthesized NPs. An instance of the satisfactory therapeutic values of AU-NPs was in an experimental diabetic mouse model that showed low levels of liver enzymes like alkaline phosphatase and alanine transaminase due to the administration of Au-NPs, which further resulted in a low level of uric acid.189 Au-NPs, formulated through Trichoderma viride bound to the drug vancomycin, have also been used as an effective treatment to suppress the outgrowth or spread of vancomycin-resistant Staphylococcus aureus to a reduced concentration of 8 μg/mL by binding the Au-NPs to the surface of the microbial cell via ionic forces. Microscopic analysis through TEM reveals that the Au-NPs bound by vancomycin had permeated the membrane of S.aureus, resulting in cell death.190 Another study concluded that tumor growth could be reduced by a concentration of 86.8% by administering doxorubicin into magnetosomes of bacteria through covalent bonding.191 A study by Brown et al concluded that the delivery efficacy of oxaliplatin, an anticancer drug, could be improved when coupled with Au-NPs that had a monolayer of thiolated polyethylene glycol crested with a carboxylate group.171

Wound Healing

The first-ever product, including nano-silver particles to be commercialized for clinical use to treat ulcers, burns, epidermal necrolysis, and several other wounds, was developed by Robert Burrell.192–194 Huang et al also employed a similar approach to enhance wound healing in which he utilized a dressing laden with NPs. This approach provided the advantage of no adverse effects on patients along with the suppression of bacterial growth resulting in a decrease in the time for wound healing over the use of the standard treatment, silver sulfadiazine.195 Another study by Sundaramoorthi et al concluded that the use of Ag-NPs biologically formulated by Aspergillus niger could be detrimental for pathogenic bacteria as it could regulate the cytokines participating in wound healing and hence had sufficient potential for the recovery of wounds.196 Marcato et al in 2015, conducted an in vivo study on biosynthesized Ag-NPs by using Fusarium oxysporum. He formulated a biogenic silver formulation and depicted that this formulation coupled with enoxaparin could be an effective treatment for wound healing, free from any side effects, with the advantages of a reduced time for both the inflammatory action and demarcation of fibroblasts into myofibroblasts.197

Cosmetology Applications of Fungal Nanoparticles

The United States Federal Food, Drug, and Cosmetic Act defines cosmetics as

articles intended to be applied to the human body by being rubbed, poured, sprinkled, or sprayed for cleansing, beautifying, promoting attractiveness, or altering the appearance (U.S. Food and Drug Administration 2016).198

“Cosmeceutical” is defined as the cosmetic agents that assert peculiar curative or healing measures. The demand for cosmetic products has upsurged over the last few years, which has amplified its growth in the international market such that it went from $US31.84 billion in the year 2016 to $US42.4 billion worth in 2018 (GBI Research; RNCOS E-Services 2016).199 Nanotechnology remains one of the most potential and promising approaches in the cosmetic industry. The efficacy of cosmetics relies on their absorption into the skin, and the smaller particles are readily absorbed into the skin. Due to their small size, the nano-emulsions show potential applications in the cosmetic industry as they form more uniform layers (films) on the skin.200 Hence, NPs are frequently employed in the formulations of various cosmetic products in the cosmeceutical arena. There is a broad scope of nanotechnology in the cosmetic and dermatological industries, as the technology is used to manufacture multiple products, including toothpastes, soaps, perfumes, sunscreens, anti-wrinkle creams, moisturizers, skin cleansers, lipsticks, hair care products, and nail care products. Based on the size and functionality of NPs, they are classified into eight classes of product, namely, cubosomes, dendrimers, niosomes, nanogold, nanocrystals, nanosilver, nanocapsules, liposomes, and solid lipid nanoparticles.200 Novel eco-friendly approaches for manufacturing metal NPs of Au, Ag and Pt are highlighted.201 The approach is considered eco-friendly because they are produced through bio-factories like plants, fungi, bacteria, and yeasts cells.169

Silver Nanoparticles as Preservatives in Cosmetics

The use of preservatives in cosmetic products is necessary not only to restrain any sort of primary contamination from microbes after the formulation of the product but also to prevent the secondary contamination when the product is opened and closed by the consumer on a daily basis.202 Chemicals agents like parabens and phenoxyethanol, antibacterial in nature, are the generally used preservatives in cosmetic products. However, they subject the skin of the consumer to some harmful side effects like skin irritation and sensitivity to UV rays.203,204 Hence, it was the need of the hour for many years to substitute these harmful chemicals with some preservatives that have an indifferent activity towards the skin and antimicrobial nature towards microbes. The solution to this problem was metal nanoparticles like Ag-NPs. Based on their antimicrobial action, they are now employed to serve as preservatives in cosmetic products.205 There is extensive use of these nanoparticles in cosmetic products, including face packs, anti-aging creams, and deodorants.200 It was stated by Gajbhiye and Sakharwade (2016) that the Ag-NPs are also used as preservatives in shampoos and toothpastes owing to their antibacterial action. Ag-NPs are biologically synthesized through Penicillium, which is an endophytic fungal genus. Saponins, tannins, flavonoids, and terpenoids identified in the extracts of the fungus Penicillium serve as capping and reducing agents to convert Ag particles into Nanoparticles.165 Capping agents like carbonyl and amide groups discovered in Ag-NPs, synthesized from the fungus Fusarium semitectum, whose size ranges from 10–60 nm, are associated with a 6–8 weeks stability. Agglomeration is dodged in the metal NPs by using capping agents that also provide the product with stability.206 These properties affect the appearance of the product by providing it with an appearance homogenous in nature and enhancing its sensory functions by preventing the sedimentation of the product for over a year.202 Metal oxides in nanoparticles like nano-titanium oxide and zinc oxide improve the feel and the spreading ability of the cosmetic product. Besides imparting these properties to the cosmetic product, they also enhance the SPF (sun protection factor) and exhibit antimicrobial action contrary to their non-nano counterparts.207

Antimicrobial Agents in Cosmetics

PAg-NPs, the nanoparticles biologically synthesized from the Penicillium spp., can suppress the growth of P. aeruginosa and E. coli at a concentration of 100-μL culture filtrate/mL pathogen broth; they exhibit a sufficiently high antibacterial activity.165 The growth of other bacteria like V. cholera, S. aureus, B. subtilis, P. aeruginosa, and E. coli can also be suppressed by the antimicrobial activity of these Ag-NPs.208,209 Fungus, including various strains of the Candida spp., including C. glabrata, C. krusei, C. albicans, C. parapsilosis, and C. tropicalis are also subjected to damage by Ag-NPs due to a damaging effect to the cell envelope of fungal cells.210 Kokura et al demonstrated that at a low concentration of 1.0 ppm, Ag-NPs exhibited antimicrobial action against the mixed bacterial extracts containing P. aeruginosa, E. coli, S. aureus and against mixed fungal extracts including A. pullulans, A. niger, C. albicans and P. citrinum found in domestic wastewater like drainage and kitchen wastewater.202 Metal NPs like nano titanium oxide (TiO2) nanoparticles are used in cosmetic products like sunscreens and other cosmeceuticals like skin milk, whitening creams, morning and night creams (AzoNano2013). At a concentration of 40 μg mL−1, the titanium oxide nanoparticles synthesised by the fungus Aspergillus flavus suppress the growth of Gram-negative bacteria, E. coli.211

Antioxidants and Anti-Inflammatory Agents in Cosmetics

As mentioned above, nanoparticles enhance the sensory character and impart stability to the cosmetic product along with a better spreading ability and sun protection.205 FRAP (Ferric Reducing Antioxidant Power) and DPPH (1,1-diphenyl-2-picrylhydrazyl)-scavenging tests confirm the substantial amount of antioxidant action of PAg-NPs. The anti-inflammatory nature was also exhibited by these NPs, as they stabilize the membranes, thereby making them suitable preservatives in cosmetic products. Besides the advantages, Ag-NPs also promote wound healing when present in cosmetic products. However, there is not much evidence regarding the anti-inflammatory nature of the fungal Ag-NPs.206,212–215 But the fact to be considered is the risk of toxicity of NPs due to their effective penetration through the skin and the supposed nano-size of the particles. Recent studies show that Ag-NPs at a concentration of 0.002–0.02 ppm permeate the skin and are swept away from the bloodstream, not causing toxicity.205

Other Applications of Fungal Nanoparticles

Metal NPs developed through fungi can potentially function as sensors for electronic devices and optical devices.216 It was reported by Fayaz et al that metal NPs like Ag-NPs synthesized by Trichoderma viride were efficiently implemented in biosensing and bio-imaging operations.217 At 320–520 nm wavelengths, these silver nanoparticles were used for blue-orange light emission. Moreover, XRD analyses and EDX (Energy Dispersive X-ray) were employed for complete characterizations of these Ag-NPs. With reference to the studies of Zheng et al, NPs of Au-Ag alloy synthesized by using yeast cells were potentially used as a novel vanillin sensor, the sensitivity of which was five times greater than other approaches. This study concluded that Ag-NPs had high potential in being utilized in the form of sensors to determine vanillin production through vanilla tea and vanilla bean quantitatively.218 The studies of Thibault et al suggested that the activity of enzyme glucose oxidase (GOx) to function as an indicator was enhanced such that the glucose content could be easily resolved in the commercial injections of glucose. Au-NPs exhibit highly sensitive detection that forms the basis of activity of Au-NP-GOx-based biosensor.219 The diverse application of various fungal nanoparticles in biomedicine is illustrated in Figure 6.

Figure 6

Diverse application of fungal based nanoparticles in the field of biomedicine.

Future Prospect and Conclusion

Microorganisms (fungi, in particular) have been extensively used in the medical industry for various treatments and preventing diseases since the last century. With the intention of determining and producing medically important molecules, several primary and secondary metabolites (antibiotics, biosurfactants, enzymes, immune suppressor substances, and organic acids) have been produced at industrial scales. Only ~5% of the fungi available naturally have been studied. It is plausible that the interest in Science and technology related to fungal nanotechnology will heighten in the future. Chemically synthesized NPs are highly toxic and pose health hazards; hence, there is a need to conclude a non-toxic production method (production of NPs via biological pathways) that seems to have already gained interest in the scientific community. The green synthesized nanoparticles are more biocompatible than their chemically synthesized counterparts. There is a tremendous commercial potential for the green-synthesized nanoparticles in the industries such as diagnostics, textile, cosmetics, and medicine, among others, because billions of dollars’ worth of investments in nanotech-based products is expected. NPs of fungal origin seem to perform better due to a higher yield of biomass, higher enzyme levels, and easier downstream processing. The residual fungal biomass can also be used in biofertilizers. However, the cost of maintaining aseptic fungal cultures is a limiting factor, which can be overcome through meticulous process design and further research on low-cost substrates. Fungal nanoparticles can be synthesized through extracellular as well as intracellular mechanisms. In the extracellular mechanisms, cell surface molecules and enzymes may act as reducing agents. Intracellular mechanisms that utilize cytoplasmic oxidoreductases are typically involved in nanoparticle synthesis. Both intracellular and extracellular NPs show various biological activities, including, but not limited to, antiproliferative, antibacterial, antifungal, anti-parasitic, and antioxidant. These activities have been proven through research on a large number of fungal strains and a wide variety of metallic nanoparticles, including Ag, Au, ZnO, Pt, and TiO2. However, more studies report antimicrobial activity as compared to other activities. Besides medical applications, the fungal synthesized nanoparticles find applications in cosmetology as preservatives, antimicrobial, and anti-inflammatory agents. A noteworthy aspect is that the cosmetology applications of the NPs are seen at very low concentrations due to high skin penetration.

Currently, a plethora of applications of the fungal-synthesized nanoparticles are paving the way for several future technologies. The use of electrospinning to produce functional nanofibrous scaffolds can potentially play significant roles in nanobiotechnology in biomedical or nanomedicine industries, for instance, removing heavy metals during waste water treatment nanomembranes for environmental applications, enzyme immobilization, tissue engineering, and drug delivery for biomedical/nanomedicine applications. Thus, these nanomaterials are biocompatible, biodegradable, sustainable, antimicrobial, and non-toxic, all of which are of great relevance in the nanotechnology industry.